Skip to content

    PUMA BIOTECHNOLOGY (PBYI) stock price & financials

    View PBYI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+77.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $80.54M
    $59.08M
    $46.01M
    $52.44M
    $54.48M
    -32.4%
    $75.45M
    +27.7%
    $44.81M
    -2.6%
    $56.50M
    +7.8%
    Strengthening
    Operating Profit
    $22.08M
    $13.37M
    $3.98M
    $6.64M
    $9.57M
    -56.6%
    $17.11M
    +28.0%
    -$3.83M
    -196.1%
    $7.58M
    +14.3%
    Weakening
    Net Profit
    $20.32M
    $19.30M
    $2.97M
    $5.86M
    $8.84M
    -56.5%
    $13.44M
    -30.4%
    -$3.75M
    -226.2%
    $8.19M
    +39.9%
    Weakening
    EPS
    $0.41
    $0.06
    $0.12
    $0.18
    -56.1%
    $-0.07
    -216.7%
    $0.16
    +33.3%
    Weakening
    Other Income
    -$1.47M
    -$1.13M
    -$717.0K
    -$471.0K
    -$330.0K
    +77.6%
    $1.0K
    $401.0K
    $660.0K
    Strengthening
    Interest
    $3.10M
    $2.62M
    $2.18M
    $1.84M
    $1.49M
    -52.0%
    $1.12M
    -57.3%
    $731.0K
    -66.4%
    $180.0K
    -90.2%
    Weakening
    Depreciation
    Profit before Tax
    $20.61M
    $12.24M
    $3.27M
    $6.17M
    $9.24M
    -55.1%
    $17.11M
    +39.8%
    -$3.43M
    -204.9%
    $8.24M
    +33.7%
    Weakening
    MarginsOPM
    27.4%
    22.6%
    8.7%
    12.7%
    17.6%
    -35.9%
    22.7%
    +0.2%
    -8.5%
    -198.6%
    13.4%
    +6.0%
    Weakening
    Tax
    1.4%
    -57.8%
    ReturnsROIC
    -1.5%
    -1.4%
    -0.2%
    -0.4%
    -0.7%
    +56.5%
    -1.0%
    +30.4%
    0.3%
    -0.6%
    -39.9%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$108.42M$60.04M$85.29M$63.13M$76.20M$84.58M$69.22M$29.64M$36.54M
    Short-Term Investments$57.00M$51.61M$8.10M$18.98M$4.87M$11.35M$31.75M$67.89M$57.37M
    Total Current Assets$203.00M$166.30M$146.14M$140.02M$134.28M$156.19M$147.66M$162.69M$145.07M
    Net PP&E$3.96M$21.83M$18.89M$15.77M$12.51M$8.65M$5.09M$5.56M$4.52M
    Goodwill
    Intangibles$44.41M$40.46M$74.14M$66.13M$70.61M$60.87M$51.13M$41.39M
    Total Assets$259.12M$234.91M$244.22M$226.59M$222.06M$230.53M$213.33M$216.30M$192.74M
    LiabilitiesTotal Current Liabilities$67.11M$90.84M$114.25M$109.59M$77.48M$99.38M$96.11M$81.25M$49.83M
    Short-Term Debt$14.29M$0$0$34.00M$45.33M$22.52M$0
    Long-Term Debt$151.89M$94.96M$84.03M$97.09M$98.31M$65.66M$21.72M$0$0
    Long-Term Leases$22.64M$19.55M$15.97M$11.83M$7.03M$1.49M$4.71M$4.37M
    Total Liabilities$224.82M$217.44M$250.17M$229.03M$200.45M$177.09M$121.21M$85.96M$54.19M
    EquityCommon Stock & APIC$4.0K$4.0K$4.0K$4.0K$5.0K$5.0K$5.0K$5.0K$5.0K
    Retained Earnings-$1.20B-$1.28B-$1.34B-$1.37B-$1.37B-$1.35B-$1.31B-$1.28B-$1.28B
    Total Equity$34.31M$17.46M-$5.95M-$2.45M$21.61M$53.44M$92.13M$130.34M$138.54M
    HighlightsNet Cash / (Debt)-$4.92M-$14.99M-$17.23M-$3.72M$33.92M$75.00M$93.90M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$24.11M$22.38M$773.0K$20.65M-$15.83M$27.01M$38.92M$41.80M$41.15M
    Cash from Investing-$57.62M$5.16M$33.40M-$10.88M$7.10M-$19.13M-$20.44M-$36.19M-$16.02M
    Cash from Financing$108.45M-$67.07M-$9.93M-$31.93M$12.22M$0-$33.85M-$45.20M-$45.34M
    SummaryCapital Expenditure-$439.0K-$306.0K-$46.0K$0$0-$140.0K-$56.0K-$71.0K$10.0K
    Free Cash Flow-$24.54M$22.07M$727.0K$20.65M-$15.83M$26.87M$38.86M$41.73M$41.16M
    FCF Margin-9.8%8.1%0.3%8.2%-6.9%11.4%16.9%18.3%17.8%

    Ratios